孵化
发表于 2025-3-21 19:01:06
书目名称Indacaterol影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0463359<br><br> <br><br>书目名称Indacaterol读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0463359<br><br> <br><br>
strdulate
发表于 2025-3-21 23:09:29
The Early Clinical Development of Indacaterol,elopment of indacaterol confirmed preclinical data characterizing indacaterol as a long-acting β.-agonist with a sustained 24 h duration of bronchodilation, thus suitable for once-daily dosing, a rapid onset of action and a favourable safety profile over a range of dosages and delivery modes, both in asthma and COPD patients of various severities.
洞穴
发表于 2025-3-22 02:04:31
Current Pharmacotherapy for COPD, a role limited to the severe and very severe patient with frequent exacerbations. Recent evidence suggests that maintenance antibiotic therapy may be additive to the effect of bronchodilators in reducing exacerbation frequency. The choice of agents may be based primarily on individual response, cost, side-effect profile, and availability.
咽下
发表于 2025-3-22 07:38:18
The Preclinical Pharmacology of Indacaterol,o systems as well as a large cohort of COPD patients, no association could be demonstrated between β.-adrenoceptor polymorphisms and indacaterol response. In conclusion, the preclinical profile of indacaterol suggests that this compound has a duration of action compatible with once-daily dosing in human, together with a fast onset of action.
五行打油诗
发表于 2025-3-22 09:59:17
http://reply.papertrans.cn/47/4634/463359/463359_5.png
nocturia
发表于 2025-3-22 13:45:41
2296-6056 cotherapy of COPD.Includes supplementary material: .Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide,
Wallow
发表于 2025-3-22 20:27:58
Indacaterol978-3-0348-0709-8Series ISSN 2296-6056 Series E-ISSN 2296-6064
pulse-pressure
发表于 2025-3-22 22:43:48
https://doi.org/10.1007/978-3-0348-0709-8Asthma; Beta-2-Agonists; Bronchitis; Bronchodilatator; Lung function
Affiliation
发表于 2025-3-23 04:12:21
Alexandre TrifilieffSummarizes preclinical and clinical data.A valuable source of information for scientists and clinicians.Contemporary monograph on the pharmacotherapy of COPD.Includes supplementary material:
开始没有
发表于 2025-3-23 07:55:35
http://reply.papertrans.cn/47/4634/463359/463359_10.png